Skip to main content
Clinical Trials/NCT03379532
NCT03379532
Completed
Not Applicable

Brain-computer Interface Controlled Neuromuscular Electrical Stimulation in Subacute Stroke

University Hospital, Geneva2 sites in 2 countries31 target enrollmentJanuary 26, 2018
ConditionsStroke

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stroke
Sponsor
University Hospital, Geneva
Enrollment
31
Locations
2
Primary Endpoint
Change in Upper Limb Fugl-Meyer Score, after treatment
Status
Completed
Last Updated
last year

Overview

Brief Summary

Stroke patients with severe upper limb movement deficits have limited treatment options and often remain severely handicapped at the chronic stage.

Recent findings have suggested that poor motor recovery can be due to severe damage of the cortico-spinal tract (CST), the neural fibres connecting the movement regions of the brain to the spinal cord. Hence, to improve recovery of upper limb movements it will be crucial to re-establish and strengthen CST projections.

Recent studies provided evidence that closed-loop brain computer interface-driven electrical stimulation of the paretic muscles can induce clinically important and lasting recovery of upper limb function, even in patients with chronic, severe motor affection. In this treatment approach, movement intentions of the patients are detected with electroencephalography and real-time analyses. This triggers an electrical stimulation of affected upper limb muscles.

In this study, the investigators hypothesize that neuromuscular electrical stimulation (NMES) applied contingent to voluntary activation of primary motor cortex, as detected by a brain-computer interface (BCI), can help restore CST projections. This might improve recovery of patients with severe upper limb movement deficits. Treatment will be started within the first 8 weeks after stroke onset.

Registry
clinicaltrials.gov
Start Date
January 26, 2018
End Date
April 30, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Adrian Guggisberg

Médecin adjoint agrégé, assistant professor

University Hospital, Geneva

Eligibility Criteria

Inclusion Criteria

  • Ischemic or hemorrhagic stroke
  • Stroke onset ≤ 8 weeks
  • Severe, unilateral motor upper extremity hemiparesis (≤15 Fugl-Meyer Score)
  • Ability to give informed consent

Exclusion Criteria

  • Second stroke during rehabilitation
  • Skull breach
  • Cardiac pacemaker
  • Metallic implants in the brain
  • Delirium or disturbed vigilance
  • Inability to follow treatments sessions
  • Severe language comprehension deficits
  • Severe dystonia or spasticity
  • Severe co-morbidity (ex, traumatic, rheumatologic, neurodegenerative diseases)
  • Pregnancy

Outcomes

Primary Outcomes

Change in Upper Limb Fugl-Meyer Score, after treatment

Time Frame: Difference between the week before the intervention and the week after intervention

Scale 0-66, higher scores indicate better outcome

Secondary Outcomes

  • Change in motor evoked potential amplitude of the paretic arm(Difference between the week before the intervention and the week after intervention)
  • Change in fractional anisotropy (FA) of the cortico-spinal tract as determined from diffusion tensor imaging(Difference between the week before the intervention and the week after intervention)
  • Change in electroencephalography functional connectivity(Difference between the week before the intervention and the week after intervention)

Study Sites (2)

Loading locations...

Similar Trials